Arbore, D.R.; Galdean, S.M.; Dima, D.; Rus, I.; Kegyes, D.; Ababei, R.G.; Dragancea, D.; Tomai, R.A.; Trifa, A.P.; Tomuleasa, C.
COVID-19 Impact on Chronic Myeloid Leukemia Patients. J. Pers. Med. 2022, 12, 1886.
https://doi.org/10.3390/jpm12111886
AMA Style
Arbore DR, Galdean SM, Dima D, Rus I, Kegyes D, Ababei RG, Dragancea D, Tomai RA, Trifa AP, Tomuleasa C.
COVID-19 Impact on Chronic Myeloid Leukemia Patients. Journal of Personalized Medicine. 2022; 12(11):1886.
https://doi.org/10.3390/jpm12111886
Chicago/Turabian Style
Arbore, Dana Raluca, Simona Maria Galdean, Delia Dima, Ioana Rus, David Kegyes, Raluca Geanina Ababei, Daniela Dragancea, Radu Andrei Tomai, Adrian Pavel Trifa, and Ciprian Tomuleasa.
2022. "COVID-19 Impact on Chronic Myeloid Leukemia Patients" Journal of Personalized Medicine 12, no. 11: 1886.
https://doi.org/10.3390/jpm12111886
APA Style
Arbore, D. R., Galdean, S. M., Dima, D., Rus, I., Kegyes, D., Ababei, R. G., Dragancea, D., Tomai, R. A., Trifa, A. P., & Tomuleasa, C.
(2022). COVID-19 Impact on Chronic Myeloid Leukemia Patients. Journal of Personalized Medicine, 12(11), 1886.
https://doi.org/10.3390/jpm12111886